2001
2002
  • First cord blood released for sibling-use.
  • Laboratory at Camden Medical Centre opened for public viewing.
2005
  • Received accreditation from American Association of Blood Banks (AABB)

    AABB's Accreditation Program strives to improve the quality and safety of collecting, processing, testing, distributing and administering blood and blood products by assessing the quality and operational systems in place within the facility.

  • Offered Medicord, a stem cell transplant insurance programme.
  • Entered Hong Kong and People's Republic of China (PRC) markets.
2007
  • Expanded to new Science Park II facility.
  • Cordlife Hong Kong achieved ISO:9001.
2008
  • Re-accredited by American Association of Blood Banks (AABB).
  • Launch of automated processing system to maximise recovery of cells for transplant use
2009
  • Re-accredited by American Association of Blood Banks (AABB).
  • First-ever release of autologous cord blood for Cerebral Palsy
  • Launched Cordlife Quality Guarantee, a warranty to protect Cordlife clients.
  • Launched Cordlife Circle, a members-only benefit programme.
  • Launched Preferential Plan upgrades for clients.
2010
  • First-ever release of autologous cord blood for Neuroblastoma.
  • Released autologous cord blood for Cerebral Palsy.
  • Celebrated enrolment of our 25,000th client.
  • Celebrated 10 years of quality cord blood banking.
2011
  • CordLife Pte Ltd renamed to "Cordlife Group Limited".
  • Launched Cordlife Care360° Safeguard programme.
  • Re-accredited by American Association of Blood Banks (AABB).
  • Launched provision of umbilical cord tissue banking services in Hong Kong.
  • Hong Kong facility accredited by American Association of Blood Banks (AABB)
2012
2013
  • Cordlife Group Limited moved to its fully owned, 23,000sqft office and laboratory facility in A'Posh Bizhub, Yishun. The facility is capable of storing up to 650,000 cord blood units.
  • First private cord blood bank in Singapore to launch automated processing system to facilitate the optimisation of cord blood stem cells for maximum transplant success*.
  • Re-accredited by American Association of Blood Banks (AABB).
  • Launched provision of umbilical cord lining banking services in Singapore with patented technology, CellOptima that is exclusively available at Cordlife capable of isolating EpSCs and MSCs, two types of stem cells present in the umbilical cord.
  • Awarded 'Most Transparent Company Award' by SIAS Investors Choice
2014
  • Processed and stored over 45,000 cord blood units as of 21 March 2014.
  • Collaborated with Make-A-Wish Foundation® (Singapore) Ltd  granting the wishes of children with life-threatening medical conditions to enrich the human experience with hope, strength and joy.
  • Enhanced Cordlife Pledge:360° assures quality processing and storage standards
2015
  • Received accreditation from FACT which ensures the global standard of excellence in patient care and laboratory practices.
  • Cordlife is one out of the six private cord blood banks worldwide that is double-accredited and the first in Southeast Asia to achieve the dual-accreditation status with AABB and FACT (The Foundation for the Accreditation of Cellular Therapy).
  • Launched the Cordlife-Jalan Kayu Pre-School Headstart Fund with a sponsorship of $150K to give young children from low-income families a chance in pre-school education.
  • Partnered with autism and epilepsy treatment pioneer, Dr Michael Chez from Sutter Medical Group and Sutter Neuroscience Institute in the continued study of autologous cord blood cells treatments.
  • Received the 16th SIAS Investors Choice Award (Runnerup), Singapore Corporate Governance Award (SCGA) 2015, Mid and Small Category.
  • Honoured by Forbes Asia as one of the "Best Under a Billion" companies in November 2015.
  • Acquired the first and largest cord blood bank in Malaysia, Stemlife Berhad as one of its subsidiaries.

 

*Conditions apply.

Our Vision

We exist to help people live longer, healthier and happier lives.

Our Mission

We provide reliable, evidence-based solutions for families to take preventive steps to improve their health and well being. Through innovation, technology and a commitment to quality, we stay with families as their lifetime healthcare partner.

Our Values

As a company, and as individuals working collectively, we value integrity, honesty, openness, pursuit of excellence, creativity, constructive self-criticism, continuous self-improvement, and mutual respect. We are committed to our clients and partners, and have a passion for innovation. We embrace big challenges and pride ourselves on seeing them through. We hold ourselves accountable to our clients, shareholders, employees and regulators by honouring our commitments, providing results and striving for the highest quality.

Cordlife Group Limited at a glance

Cordlife Group Limited ("Cordlife", together with its subsidiaries, the "Group") is a consumer healthcare company catering to the mother and child segment. Established in May 2001 and successfully listed on the Mainboard of Singapore Exchange Trading Limited ("SGX-ST") in 2012, the Group is one of the pioneers in the cord blood banking industry in Asia.

Cordlife is amongst the leading players for private cord blood banking services in all the markets it operates in, namely Singapore, Hong Kong, Malaysia, India, Indonesia and the Philippines. Inhabiting a distinctive niche in the healthcare industry, the Group is one of the foremost private cord blood banks to have gained a solid foothold in Asia. In the last 16 years, Cordlife has dedicated its undertakings to achieve market leadership in the industry. Having built a distinguished brand name, the Group continues to strive for excellence by means of support from its experienced management team, dynamic key executives along with its quality product and service offerings. Cordlife believes the Group has in place a strong foundation for future expansion.

The Group's processing and storage facilities in Hong Kong, India and Singapore are accredited by AABB, the world's gold standard in cord blood banking and its facilities in Indonesia and the Philippines are also ISO-certified. Cordlife Singapore achieved accreditation by FACT-Netcord, making it one of only six cord blood banks in the world to achieve accreditations from both AABB and FACT-Netcord simultaneously. . The Group’s majority owned Hong Kong and India subsidiaries, Hong Kong Screening Centre Limited (“HKSC”) and Cordlife Sciences (India) Pvt. Ltd. (“Cordlife India”), have also received accreditation from the College of American Pathologists (“CAP”), which is awarded to facilities that meet or exceed the highest standards in laboratory services. In July 2017, Cordlife Philippines became the first cord blood bank in the country to be accredited by AABB.

Cordlife Group Limited
1 Yishun Industrial Street 1, #06-01/09 A'Posh Bizhub Singapore 768160

Tel: (65) 6238 0808
Fax: (65) 6238 1108
Website: www.cordlife.com
Email: info@cordlife.com
Cordlife Sciences India Pvt. Ltd.

Corporate Identity Number: U85196WB2005PTC106719
Registered Office:
P.L. Deuty Road, off Diamond Harbour Road Bishnupur,
24 Parganas (S) West Bengal - 743503, India

Toll Free: 1800 345 6200
Tel: (91) 98 30166200
Fax: (91) 33 24809566

Cordlife Medical Philippines, Inc.

Unit 104 Building H UP-AyalaLand TechnoHub Commonwealth Ave. Bgy. UP Campus, Diliman Quezon City Philippines 1101

Mobiles: +63 998 848 6063 | +63 998 848 6064
Landlines : (02) 470 1735 | (02) 332 1888 
Website: www.cordlife.com.ph
Email: info@ph.cordlife.com

PT. Cordlife Persada

Corporate Office and Laboratorium
Infinia Park Blok C 100,
Jl. Dr. Sahardjo No.45, Manggarai - Tebet,
Jakarta Selatan, 12850 Indonesia

Tel: (+62) 21-8379-7424
Fax: (+62) 21-8379-7425
Email: info@id.cordlife.com

Cordlife (Hong Kong) Ltd.

Main Office:
Suite 3603A, 36/F, Skyline Tower,39 Wang Kwong Road, Kowloon Bay, Kowloon

Laboratory:
Unit G15,G/F, Biotech Centre 2 No. 11
Science Park West Avenue Shatin
New Territories, Hong Kong

Tel: (852) 3980 2980
Fax: (852) 25118882
Email: info@hk.cordlife.com

Cord Blood/Umblical Cord Enquiry Hotline:
(852) 3980 2888

Cord Blood/Umblical Cord Collection Hotline:
(852) 3980 2999

Macau

c/o Fleet Company Ltd. Rua De Coelho Do Amaral No. 91R/C, Macau

Tel: (853) 2835 2266
Fax: (853) 2835 2180
Email: info@mo.cordlife.com

StemLife Malaysia

B-7-15, Megan Avenue II,
12 Jalan Yap Kwan Seng,
50450 Kuala Lumpur, Malaysia

24hr Hotline: +603 2166 3636
Tel : +603 2163 8800
Fax : +603 2164 9808
Email: info@stemlife.com 

Cordlife Myanmar

Marketed by BIO Secure Co., Ltd.

631 Pyay Road,
Kamaryut Township, Yangon
Myanmar 11041

24 Hour Hotline 09 2652 88882

Cordlife Vietnam

Hotline +84 98 355 1644

We adhere to the best practices and follow the stringent protocols from the collection to the processing and storage of your Child's cord blood. Cordlife Group Limited is the longest operating cord blood bank in Singapore since 2001 with over 50,000* families entrusting their baby's cord blood with us.

Since our inception, we have established a quality system and proven track record of reliable cord blood banking services and transplant use track record.

Our emphasis and commitment to quality was recognized when our facility in Singapore was internationally accredited by AABB (formerly known as the American Association of Blood Banks) in 2005, and subsequently reaccredited five more times. As of November 2015, Cordlife has been further accredited by FACT (Foundation for the Accreditation of Cellular Therapy).

ABOUT AABB

Originally named the "American Association of Blood Banks", AABB is a non-profit international association of organizations and individuals who are involved in transfusion and cell transplantation medicine. The list of AABB Accredited Cord Blood Facilities is online and updated regularly. AABB accredited facilities are inspected every two years, and the AABB standards are updated on a two-year cycle by subject matter experts to reflect the evolving nature of the field.

AABB was founded in 1947 and is headquartered in Bethesda, Maryland, USA. Over the years they have developed voluntary accreditation standards for various types of blood banks, transfusion services, and laboratories.

ABOUT FACT

The Foundation for the Accreditation of Cellular Therapy (FACT), also a non-profit corporation, was co-founded by the International Society for Cellular Therapy (ISCT) and the American Society of Blood and Marrow Transplantation (ASBMT) in 1996.

FACT is the leader in international standards for cellular therapy, used in Europe, USA, Canada, Australia and New Zealand. The FACT accreditation, a symbol of excellence, has stringent standards, with rigorous and thorough inspections across organizations' processes and practices. Organizations that achieve the FACT accreditation have demonstrated that their patient care and laboratory practices are of exceptional quality, and are in compliance to the highest international standards.

*Figure as at 31 December 2014.

Page 2 of 2